Breast cancer
N Harbeck, F Penault-Llorca… - Nature reviews …, 2019 - mayoclinic.elsevierpure.com
Breast cancer is the most frequent malignancy in women worldwide and is curable in~ 70–
80% of patients with early-stage, non-metastatic disease. Advanced breast cancer with …
80% of patients with early-stage, non-metastatic disease. Advanced breast cancer with …
Molecular classification of breast cancer
JYS Tsang, MT Gary - Advances in anatomic pathology, 2020 - journals.lww.com
Cancer classification aims to provide an accurate diagnosis of the disease and prediction of
tumor behavior to facilitate oncologic decision making. Traditional breast cancer …
tumor behavior to facilitate oncologic decision making. Traditional breast cancer …
Breast cancer: a molecularly heterogenous disease needing subtype-specific treatments
U Testa, G Castelli, E Pelosi - Medical Sciences, 2020 - mdpi.com
Breast cancer is the most commonly occurring cancer in women. There were over two-
million new cases in world in 2018. It is the second leading cause of death from cancer in …
million new cases in world in 2018. It is the second leading cause of death from cancer in …
A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations
TP Reddy, RR Rosato, X Li, S Moulder… - Breast Cancer …, 2020 - Springer
Metaplastic breast cancer (MpBC) is an exceedingly rare breast cancer variant that is
therapeutically challenging and aggressive. MpBC is defined by the histological presence of …
therapeutically challenging and aggressive. MpBC is defined by the histological presence of …
Germline pathogenic variants in metaplastic breast cancer patients and the emerging role of the BRCA1 gene
Metaplastic breast cancer (MpBC) is a rare, aggressive breast cancer (BC) histotype. Scarce
information is available about MpBC genetic predisposition. Previous studies, mainly …
information is available about MpBC genetic predisposition. Previous studies, mainly …
[HTML][HTML] Breast tumor-on-chip models: From disease modeling to personalized drug screening
Breast cancer is one of the leading causes of mortality worldwide being the most common
cancer among women. Despite the significant progress obtained during the past years in the …
cancer among women. Despite the significant progress obtained during the past years in the …
Collective metastasis: coordinating the multicellular voyage
E Wrenn, Y Huang, K Cheung - Clinical & experimental metastasis, 2021 - Springer
The metastatic process is arduous. Cancer cells must escape the confines of the primary
tumor, make their way into and travel through the circulation, then survive and proliferate in …
tumor, make their way into and travel through the circulation, then survive and proliferate in …
Spindle cell lesions of the breast: a diagnostic approach
EA Rakha, E Brogi, I Castellano, C Quinn - Virchows Archiv, 2022 - Springer
Spindle cell lesions of the breast comprise a heterogeneous group of lesions, ranging from
reactive and benign processes to aggressive malignant tumours. Despite their rarity, they …
reactive and benign processes to aggressive malignant tumours. Despite their rarity, they …
Molecular features of metaplastic breast carcinoma: an infrequent subtype of triple negative breast carcinoma
S González-Martínez, B Pérez-Mies, I Carretero-Barrio… - Cancers, 2020 - mdpi.com
Metaplastic breast carcinoma (MBC) is a heterogeneous group of infrequent invasive
carcinomas that display differentiation of the neoplastic epithelium towards squamous cells …
carcinomas that display differentiation of the neoplastic epithelium towards squamous cells …
Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1
E Kalaw, M Lim, JR Kutasovic, A Sokolova… - British Journal of …, 2020 - nature.com
Background Metaplastic breast carcinoma encompasses a heterogeneous group of tumours
with differentiation into squamous and/or spindle, chondroid, osseous or rhabdoid …
with differentiation into squamous and/or spindle, chondroid, osseous or rhabdoid …